National telehealth company Bicycle Health says if the proposed Drug Enforcement Administration rule requiring an in-person visit for a prescription of buprenorphine takes effect, patients around the country will face the same problems accessing the preeminent opioid use disorder treatment that have occurred over the last eight months in Alabama.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us